17-61859862-G-C

Variant summary

Our verdict is Uncertain significance.
+4 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 4 classification points (ACMG Germline Pathogenicity v2019). PS3PP3BP6

The NM_032043.3(BRIP1):c.139C>G (p.Pro47Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000355 (AC=573) in the gnomAD database across 1,613,850 control chromosomes, including 1 homozygote. The grpmax filtering allele frequency (95% CI) is 0.000425. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.46). Variant has been reported in ClinVar as Benign/Likely Benign (no review stars). ClinVar reports functional evidence for this variant: "SCV001167103: The helicase activity of the P47A mutant protein is defective, as described by Cantor, and BRIP1 is an interacting BRCA1 protein, we consider this mutation to be clinically important and treatment target in our patient. PMID:11301010, PMID:18473727, https://doi.org/10.2217/fon.10.191". Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.P47H: Uncertain_significance (ClinVar VariationId 3228087, 1 star); p.P47= (synonymous): Benign/Likely_benign (ClinVar VariationId 2032308, 2 stars); p.P47R: Uncertain_significance (ClinVar VariationId 3482466, 2 stars); p.P47S: Uncertain_significance (ClinVar VariationId 4082934, 2 stars); p.P47T: Uncertain_significance (ClinVar VariationId 182340, 2 stars) This exact variant is established as oncogenic in: CGI (Cancer Genome Interpreter). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00037 ( 1 hom. )

Consequence

BRIP1
NM_032043.3 missense

Scores

10
7
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:24B:9

Conservation

PhyloP100: 8.46

Publications

47 publications found
Variant links:
Genes affected
BRIP1 (HGNC:20473): (BRCA1 interacting helicase 1) The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
BRIP1 Gene-Disease associations (from GenCC):
  • familial ovarian cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • Fanconi anemia complementation group J
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • colorectal adenoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_032043.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 points.

PS3
Well-established functional study supports damaging effect (PS3); SCV001167103: The helicase activity of the P47A mutant protein is defective, as described by Cantor, and BRIP1 is an interacting BRCA1 protein, we consider this mutation to be clinically important and treatment target in our patient. PMID:11301010, PMID:18473727, https://doi.org/10.2217/fon.10.191
PP3
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting).
BP6
ClinVar 0-star benign — supporting (BP6); ClinVar germline classification: Benign/Likely Benign, 0 star(s).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_032043.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRIP1
NM_032043.3
MANE Select
c.139C>Gp.Pro47Ala
missense
Exon 3 of 20NP_114432.2Q9BX63-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRIP1
ENST00000259008.7
TSL:1 MANE Select
c.139C>Gp.Pro47Ala
missense
Exon 3 of 20ENSP00000259008.2Q9BX63-1
BRIP1
ENST00000682453.1
c.139C>Gp.Pro47Ala
missense
Exon 4 of 21ENSP00000506943.1Q9BX63-1
BRIP1
ENST00000683039.1
c.139C>Gp.Pro47Ala
missense
Exon 4 of 21ENSP00000508303.1Q9BX63-1

Frequencies

GnomAD3 genomes
AF:
0.000230
AC:
35
AN:
152158
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000247
AC:
62
AN:
251410
AF XY:
0.000265
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000466
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000368
AC:
538
AN:
1461574
Hom.:
1
Cov.:
30
AF XY:
0.000396
AC XY:
288
AN XY:
727094
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33476
American (AMR)
AF:
0.000112
AC:
5
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39658
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86240
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53396
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.000459
AC:
510
AN:
1111810
Other (OTH)
AF:
0.000232
AC:
14
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.447
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000230
AC:
35
AN:
152276
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41550
American (AMR)
AF:
0.0000654
AC:
1
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000412
AC:
28
AN:
68016
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000375
Hom.:
0
Bravo
AF:
0.000223
EpiCase
AF:
0.000382
EpiControl
AF:
0.00107

Local populations

Turkish Variome
AF:
0.00104
AC:
7
AN:
6724
Hom.:
0
ABraOM SABE-WGS-1171
AF:
0.000427
AC:
1
AN:
2342
Hom.:
0

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
9
1
not provided (10)
-
1
4
Hereditary cancer-predisposing syndrome (5)
-
3
-
Familial cancer of breast (3)
-
3
-
Fanconi anemia complementation group J (3)
-
1
2
not specified (3)
1
1
-
Breast cancer, early-onset (2)
-
1
1
Familial cancer of breast;C1836860:Fanconi anemia complementation group J (2)
1
1
-
Malignant tumor of breast (2)
-
1
-
Breast and/or ovarian cancer (1)
-
1
-
BRIP1-related disorder (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
1
-
Monogenic short stature (1)
-
1
-
Ovarian cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.72
BayesDel_addAF
Uncertain
0.11
D
BayesDel_noAF
Pathogenic
0.26
CADD
Pathogenic
27
DANN
Benign
0.95
DEOGEN2
Uncertain
0.66
D
Eigen
Pathogenic
0.84
Eigen_PC
Pathogenic
0.81
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
1.0
D
M_CAP
Uncertain
0.12
D
MetaRNN
Uncertain
0.70
D
MetaSVM
Uncertain
0.013
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
8.5
PrimateAI
Uncertain
0.76
T
PROVEAN
Pathogenic
-6.5
D
REVEL
Pathogenic
0.70
Sift
Benign
0.055
T
Sift4G
Pathogenic
0.0
D
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.40
gMVP
0.84
Mutation Taster
=26/74
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.